Home
Company
About us
Genito-urinary diseases
Governance
Board of Directors
Scientific Advisory Board
Management
R&D
Pipeline
Litoxetine (IXA-001)
IXA-002 & IXA-003
MAGenTA
Press
Contact
Management
Home
/
Management
Roberto Gradnik
CEO
Nathalie de Valleuil
Office & Communication Manager
Elisabeth Svanberg
Chief Development Officer
